AU2003288214A1 - Nasal pharmaceutical preparation containing an active lipophilic liquid or gaseous ingredient - Google Patents

Nasal pharmaceutical preparation containing an active lipophilic liquid or gaseous ingredient

Info

Publication number
AU2003288214A1
AU2003288214A1 AU2003288214A AU2003288214A AU2003288214A1 AU 2003288214 A1 AU2003288214 A1 AU 2003288214A1 AU 2003288214 A AU2003288214 A AU 2003288214A AU 2003288214 A AU2003288214 A AU 2003288214A AU 2003288214 A1 AU2003288214 A1 AU 2003288214A1
Authority
AU
Australia
Prior art keywords
pharmaceutical preparation
preparation containing
lipophilic liquid
nasal pharmaceutical
active lipophilic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003288214A
Other languages
English (en)
Inventor
Michael Georgieff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2003288214A1 publication Critical patent/AU2003288214A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2003288214A 2002-12-06 2003-12-02 Nasal pharmaceutical preparation containing an active lipophilic liquid or gaseous ingredient Abandoned AU2003288214A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10257180.5 2002-12-06
DE10257180 2002-12-06
PCT/EP2003/013591 WO2004052337A2 (de) 2002-12-06 2003-12-02 Nasale pharmazeutische präparation enthaltend eine lipophile flüssige oder gasförmige wirksubstanz

Publications (1)

Publication Number Publication Date
AU2003288214A1 true AU2003288214A1 (en) 2004-06-30

Family

ID=32477447

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003288214A Abandoned AU2003288214A1 (en) 2002-12-06 2003-12-02 Nasal pharmaceutical preparation containing an active lipophilic liquid or gaseous ingredient

Country Status (2)

Country Link
AU (1) AU2003288214A1 (de)
WO (1) WO2004052337A2 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19709704C2 (de) * 1997-03-10 1999-11-04 Michael Georgieff Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
GB9913677D0 (en) * 1999-06-11 1999-08-11 Imperial College Formulation
DE10045845A1 (de) * 2000-09-14 2002-04-04 Messer Griesheim Gmbh Xenon als Arzneimittel

Also Published As

Publication number Publication date
WO2004052337A3 (de) 2004-09-30
WO2004052337A2 (de) 2004-06-24

Similar Documents

Publication Publication Date Title
IL163866A0 (en) 8-Azaprostaglandin derivative compounds and drugs containing the compounds s active ingredient
AU2002342050A1 (en) Anesthesia drug monitor
IL164699A0 (en) Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
HUP0700039A2 (en) Use of cannabinoid drugs for the preparation of medicines for decreasing cell proliferation
SI1608362T1 (sl) Stabiliziran farmacevtski izdelek z amorfno aktivno učinkovino
AU2001234114A1 (en) Drugs containing combined active ingredients
AU2002257582A1 (en) Pharmaceutical formulation
AU2003243439A1 (en) Medical device for intra-lumenal delivery of pharmaceutical agents
AU2001278772A1 (en) Benzoic acid derivatives and drugs containing the same as the active ingredient
EP1539156B8 (de) Flüssige dosierformen säurelabiler arzneimittel
AU2001277738A1 (en) Piperidine derivatives and drugs containing these derivatives as the active ingredient
AU2003238039A1 (en) Nasal peptide pharmaceutical formulation
AU2001267887A1 (en) Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components
AU2002361473A1 (en) Unit for delivering a single dosage of a liquid medicine
AU2001260089A1 (en) Pharmaceutical compositions comprising desglymidodrine as an active drug substance
AU2003288214A1 (en) Nasal pharmaceutical preparation containing an active lipophilic liquid or gaseous ingredient
AU2003203233A1 (en) N-substituted sulfonamide derivatives and preventive or therapeutic drugs for diabetes containing the same
AU2002212863A1 (en) Stable pharmaceutical form of an anticancer drug
AU2001274236A1 (en) Dry-powder pharmaceutical formulation for inhalation comprising alpha4-intergrinantagonist
AU2002333235A1 (en) Pharmaceutical formulation containing an LTB4 antagonist
AU2002363776A1 (en) Carboxylic acid derivative compounds and drugs containing the same as the active ingredient
IL161768A0 (en) Carboxylic acid derivative compounds and drugs containing the same as the active ingredient
GB0201607D0 (en) Formulation for the administration of medicinal substances
AU2001295884A1 (en) Dispenser for endermic administration of drug
AU2002238748A1 (en) Pharmaceutical aerosol formulation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase